Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-20
2009-08-04
Kolker, Daniel E. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S007100
Reexamination Certificate
active
07569545
ABSTRACT:
Methods of treating brain tissue damage and increasing expression of a trophic factor in a cell.
REFERENCES:
patent: 6749850 (2004-06-01), Finkelstein et al.
patent: 6761888 (2004-07-01), Schenk
patent: 2004/0019184 (2004-01-01), Fukuda et al.
patent: 2004/0120925 (2004-06-01), Toda et al.
patent: 2004/0265971 (2004-12-01), Sato et al.
patent: 00/50568 (2000-08-01), None
Definition of Neurotrophic Factor, Medline Plus online dictionary, accessed Mar. 24, 2008.
Zhao 2002 (Experimental Neurology 174:11-20).
Schabitz et al. 2003. Stroke 34:745-751.
Modo 2004 (NeuroImage 21:311-317).
Borlongan, Cesar V. and David C. Hess, “G-CSF-Mobilized Peripheral Blood from Transplantation Therapy in Stroke,”Cell Transplantation, 12:447-448 (2003).
Cao et al., “Stem Cell Repair of Central Nervous System Injury,”Journal of Neuroscience Research, 68:501-510 (2002).
Corti et al., “Modulated Generation of Neuronal Cells from Bone Marrow by Expansion and Mobilization of Circulating Stem Cells with In Vivo Cytokine Treatment,”Experimental Neurology, 177:443-452 (2002).
Gerstring et al., “Effects of Enterally Administering Granulocyte Colony-Stimulating Factor to Suckling Mice,”Pediatric Research, 55(5):802-806 (2004).
Maianski et al., “Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis are Inhibited by Granulocyte Colony-Stimulating Factor,”The Journal of Immunology, 172:7024-7030 (2004).
Ricciardi et al., “Apoptosis Susceptibility and Cell-Cycle Distribution in Cells from Myelodysplastic Syndrome Patients: Modulatory In-Vitro Effects of G-CSF and Interferon-α,”Leukemia&Lymphoma, 45(7):1437-1443 (2004).
Rudolf et al., “Clozapine-induced Agranulocytosis and Thrombopenia in a Patient with Dopaminergic Psychosis,”J. Neural. Transm. 104:1305-1311 (1997).
Savitz et al., “Cell Transplants Offer Promise for Stroke Recovery,”The Journal of Cardiovascular Nursing, 18(1):57-61 (2003).
Schäbitz et al., “Neuroprotective Effect of Granulocyte Colony-Stimulating Factor After Focal Cerebral Ischemia,”Stroke, 34:745-751 (2003).
Six et al., “Beneficial Effect of Pharmacological Mobilization of Bone Marrow in Experimental Cerebral Ischemia,”European Journal of Pharmacology, 458:327-382 (2003).
Willing et al. “Mobilized Peripheral Blood Cells Administered Intravenously Produce Functional Recovery in Stroke,”Cell Transplantation, 12:449-454 (2003).
Li Hung
Lin Shinn-Zong
Shyu Woei-Cherng
Academia Sinica
Kolker Daniel E.
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Methods of increasing neurotrophic factor expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of increasing neurotrophic factor expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of increasing neurotrophic factor expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4096445